Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate and prophylactic autologous peripheral blood stem cell collection using single-agent plerixafor
jRCTs031250403Active, not recruiting
- Sponsor
- Japan Ministry of Defence
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of plerixafor in Acute Radiation Syndrome (ARS), sponsored by Japan Ministry of Defence. Started Dec 2025; status: active, not recruiting.
02
Drugs
plerixafor
03
Conditions
Acute Radiation Syndrome (ARS)
Beyond the preview
Go deeper on jRCTs031250403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250403.